Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection


BACKGROUND The efficacy and safety of direct-acting antivirals (DAAs) for treating hepatitis C virus (HCV)-infected renal transplant recipients (RTRs) has not been determined. METHODS We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials and assessed the quality of eligible studies using the Joanna Briggs Institute scale. DAA… (More)
DOI: 10.1097/MD.0000000000007568


7 Figures and Tables

Slides referencing similar topics